Monsanto Technology LLC

Joel E Ream

Clayton T Larue

Xuefeng Zhou

Farhad Moshiri

Artem G Evdokimov

Ganesh M Kishore

Gregory R Heck

Yuanji Zhang

Tedd D Elich

Scott R Baerson

Aabid Shariff

Kenneth John Piller

Sherri M Brown

Sudabathula R Rao

Eugene W Logusch

Sherry J Logusch

Luis Jurado

The invention relates to biotechnology and provides novel recombinant DNA molecules and engineered proteins for conferring tolerance to protoporphyrinogen oxidase-inhibitor herbicides. The invention also provides herbicide tolerant transgenic plants, seeds, cells, and plant parts containing the recombinant DNA molecules, as well as methods of using the same.

Methods and compositions for PPO herbicide tolerance in plants

The invention provides recombinant DNA molecules useful for providing efficient expression of proteins in transgenic plants, as well as compositions and methods for using the recombinant DNA molecules. In particular embodiments, the invention provides recombinant DNA molecules and constructs comprising sequences encoding transit peptides and operably linked sequences conferring herbicide tolerance.

Methods and compositions for gene expression in plants

Polypeptides for PPO herbicide tolerance in plants

Methods and compositions for PPO herbicide tolerance

Methods and compositions for herbicide tolerance in plants

Methods and systems for analyzing soybeans and, more particularly, for analyzing soybeans at the point of delivery such as a grain elevator or processing plant for a characteristic of the soybeans such as the &#x3b2;-conglycinin protein content or the intensity of flavor of the soybeans.

Methods and systems for differentiating soybeans

Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-&#x3b2; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3&#x3b2;-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2&#x3b2;,3&#x3b2;-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.

Methods for controlling gibberellin levels

Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase, 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing antisense RNA which suppresses the gibberellin biosynthetic pathway sequence. The antisense sequence is the complement of a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, or a C20-oxidase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.

Growing community of inventors

St. Louis, MO, United States of America

Joel E Ream